Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biovie (BIVI) EBIT: 2017-2025

Historic EBIT for Biovie (BIVI) over the last 7 years, with Jun 2025 value amounting to -$3.7 million.

  • Biovie's EBIT rose 23.53% to -$3.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$18.1 million, marking a year-over-year increase of 43.86%. This contributed to the annual value of -$18.1 million for FY2025, which is 43.86% up from last year.
  • Biovie's EBIT amounted to -$3.7 million in Q2 2025, which was down 22.58% from -$3.0 million recorded in Q1 2025.
  • Biovie's 5-year EBIT high stood at -$3.0 million for Q1 2025, and its period low was -$131.6 million during Q2 2021.
  • For the 3-year period, Biovie's EBIT averaged around -$7.5 million, with its median value being -$7.5 million (2024).
  • In the last 5 years, Biovie's EBIT plummeted by 22,709.25% in 2021 and then soared by 92.94% in 2022.
  • Quarterly analysis of 5 years shows Biovie's EBIT stood at -$6.7 million in 2021, then tumbled by 72.46% to -$11.5 million in 2022, then climbed by 23.61% to -$8.8 million in 2023, then grew by 16.95% to -$7.3 million in 2024, then grew by 23.53% to -$3.7 million in 2025.
  • Its EBIT was -$3.7 million in Q2 2025, compared to -$3.0 million in Q1 2025 and -$7.3 million in Q4 2024.